Table 6A.
Study | Temperature / °C | pH | Buffer | Study duration | Polysorbate / % (w/v) | Polysorbate |
---|---|---|---|---|---|---|
Kranz et al. (2019) (Kranz et al., 2019) | 40 | 6.0 | 10 mM His, 8 % (w/v) sucrose | 17 d | 0.04 | PS20 MC PS80 MC/AO |
40 | 6.0 | 10 mM His, 8 % (w/v) sucrose, 50 μM EDTA | 7 d 17 d |
0.04 | PS20 MC/AL PS80 MC/AO |
|
40 | 5.5 | 10 mM AcOH, 8 % (w/v) sucrose | 17 d | 0.04 | PS20 MC/AL PS80 MC/AO |
|
Bensaid et al. (2022) (Bensaid et al., 2022) | 25 | 6.0 | 20 mM His, 20 mg·mL-1 mAb1, 10 % (w/v) sucrose | 3 m | 0.02 | PS80 MC/AO |
40 | 1 m | |||||
40 | 5.0, 6.0 | 20 mM citrate, 20 mg·mL-1 mAb, 10 % (w/v) sucrose, 30 ppb Fe(lI)Cl2 x 4 H2O | 1 m | 0.05 | PS80 MC | |
40 | 7.0 | 20 mM His, 20 mg·mL-1 mAb, 10 % (w/v) sucrose, 30 ppb Fe(lI)Cl2 x 4 H2O | 1 m | 0.05 | PS80 MC | |
40 | 5.0, 6.0 | 20 mM AcOH, 20 mg·mL-1 mAb, 10 % (w/v) sucrose, 30 ppb Fe(lI)Cl2 x 4 H2O | 1 m | 0.05 | PS80 MC | |
Dahotre et al. (2018) (Dahotre et al., 2018) | 2-8 | 5.4 | His-AcOH | 0, 12, 18, 24 m | 0.04 | PS20 (quality not defined) |
2-8 | 5.5 | His-AcOH | 13, 32 m | 0.02 | PS20 (quality not defined) | |
Kishore et al. (2011) (Kishore et al., 2011a) | 5 | 6.0 | 20 mM His, 10 mg·mL-1 mAb1, 240 mM trehalose | 12 m | 0.05 | PS20 or PS80 (quality not defined) |
5 | 6.0 | 20 mM His, 10 mg·mL-1 mAb2, 240 mM trehalose | 12 m | 0.01-0.04 | PS20 and PS80 (quality not defined) | |
5 | 6.0 | 25 mM Na-AcOH, mAb3 10 mg·mL-1, 125 mM NaCl | 12 m | 0.025 | PS20 (quality not defined) | |
5 | 5.5 | 20 mM His/His-Cl, mAb4 25 mg·mL-1, 240 mM trehalose | 24 m | 0.02 | PS80 (quality not defined) | |
Doshi et al. (2020) (Doshi et al., 2020a) | 40 | 5.5 | His-AcOH, 10 mg·mL-1 IgG1 mAb, sucrose | 1 m | 0.03 | PS20 HP/SR |
25 | 3 m | |||||
2-8 | 12 m | |||||
Gopalrathnam et al. (2018) (Gopalrathnam et al., 2018) | 5, 25 | 5.5-6.0 | 10 mM His, 150 mM NaCl, 5, 40, 70, 100, 120 mg·mL-1 LY2951742 antibody |
10 m | 0.05-0.06 | PS80 (quality not defined) |
Borisov et al. (2015) (Borisov et al., 2015) | 40 | - | Water, 1.5-10 mM AAPH | 19 h 40 h |
0.004 | PS20 (quality not defined) |
40 | - | Water, 1.5-10 mM AAPH | 12.5 h 40 h |
0.004 | PS80 (quality not defined) | |
Kranz et al. (2020) (Kranz et al., 2020) | 40 | 6.0 | His 10 mM, 8 % (w/v) sucrose, 10 ppb Fe(II)SO4 | 12 d | 0.04 | PS20 MC/AL PS80 MC/AO |
Ha et al. (2002) (Ha et al., 2002) | 40, 50, 60 | - | Water | 8 w | Neat and 20 | PS80 NF grade Low peroxide PS80 |
Yao et al. (2009) (Yao et al., 2009) | 40 | 7.0 | 100 mM Sodium phosphate, 0.1 mM EDTA | - | - | PS20 PS80 high grades |
Kishore et al. (2010) (Kishore et al., 2011b) | 5, 25, 40 | 5.5 | 20 mM His, 240 mM trehalose, 10 mg·mL-1 mAb1 or placebo | 12 m | 0.05 or 0.03 | PS20 or PS80 (quality not defined) |
Liu et al. (2021) (Liu et al., 2022a) | 25 | 6.0 | Water | 11-20 m | 0.05 | PS80 MC/ChP |
Donbrow et al. (1978) (Donbrow et al., 1978a) | 25, 40, 60, 70 | 6.0 | Buffer, potassium iodide | 30 d | 1 | PS20 (quality not defined) |
Doyle et al. (2019) (Doyle et al., 2019) | 50 | 5.5 | 10 mM His, citrate, phosphate | 30 d | 0.02 | PS80 MC |
Schmidt et al. (2020) (Schmidt et al., 2020) | 40 | - | Water | 7 w | 10 | PS20 and PS80 containing either no antioxidant or BHT or BHA at a concentration of 0.02 % (v/w) |
Zhang et al. (2018) (Zhang et al., 2018) | 40 | 5.5 | 20 mM Na-AcOH or 20 mM His, or His-AcOH | 8 w | 0.02 | PS20 HP |
Schröter et al. (2020) (Schröter et al., 2021) | RT | Acidic | Water + trifluoroacetic acid (0.5 mM), 10 mM H2O2, 0.1 mM Fe(II)SO4 | 5 w | 10 | PS80 (no BHT, 1 mM BHT, 0.3 mM BHT) |
40 | Acidic | Water + trifluoroacetic acid (0.5 mM), 1.5 mM AAPH | 5 w | 10 | PS80 (no BHT, 1 mM BHT, 0.3 mM BHT) | |
Zhang et al. (2017) (Zhang et al., 2017) | 40 | 1 7 11 |
Water, 1.5 mM AAPH | 12, 24, 36, 48 h | 0.1 | PS20 AL |
Agarkhed et al. (2012) (Agarkhed et al., 2013) | 25 | 6.0 | 10 mM His, NaCl, glycine, 5 mg·mL-1 mAb | 6 d | 0.01 | PS80 (SR, NF, ultrapure) |